ProCE Banner Activity

CE / CME

Expert Insights Into Optimal Outpatient Management of Acute and Long COVID-19

Multimedia

In this on-demand webcast from a live symposium at IDWeek 2022, expert faculty discuss COVID-19 testing, diagnosis, and risk stratification COVID-19 therapeutic options for nonhospitalized patients and long COVID.

Pharmacists: 2.00 contact hours (0.2 CEUs)

Physicians: Maximum of 2.00 AMA PRA Category 1 Credits

Released: December 12, 2022

Expiration: December 11, 2023

No longer available for credit.

Share

Faculty

Fernando Carnavali

Fernando Carnavali, MD

Associate Professor of Medicine
Division Chief
General Internal Medicine
Department of Medicine
Mount Sinai Health System
New York, New York

Rasika Karnik

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Joseph Torrisi

Joseph Torrisi, PharmD, BCIDP

Clinical Pharmacy Specialist – Infectious Diseases
Grady Health System
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Pfizer, Inc.

Target Audience

This program is intended for physicians, pharmacists, and other HCPs involved in the management of nonhospitalized patients with current or previous COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize outpatient management of acute COVID and post-COVID conditions.

Program Learning Goal

To improve healthcare professionals’ (HCPs) competence in optimizing outpatient management of COVID-19, including timely diagnosis, risk stratification, and treatment, and to expand HCPs’ ability to apply emerging data on the epidemiology, presentation, and emerging data regarding prevention and management of post-COVID conditions.

Learning Objectives

  • Implement strategies to ensure equitable and timely COVID-19 testing and diagnosis
  • Utilize best practices for risk stratification of nonhospitalized patients with COVID-19 to determine eligibility for outpatient treatment
  • Develop individualized care plans for outpatients diagnosed with SARS-CoV-2 infection based on guideline recommendations, current clinical data, and potential logistical or supply constraints
  • Apply approaches to preventing and managing post-COVID conditions based on emerging data and current best practices

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director Disclosure

Program Director

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: unrestricted research grant: Gilead Sciences.

Faculty Disclosure

Primary Author

Fernando Carnavali, MD

Associate Professor of Medicine
Division Chief
General Internal Medicine
Department of Medicine
Mount Sinai Health System
New York, New York

Fernando Carnavali, MD, has no relevant financial relationships to disclose.

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Rasika Karnik, MS, MD: consultant/advisor/speaker: Gilead Sciences.

Joseph Torrisi, PharmD, BCIDP

Clinical Pharmacy Specialist – Infectious Diseases
Grady Health System
Atlanta, Georgia

Joseph Torrisi, PharmD, BCIDP, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Credit Designation

CCO designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-305-H01-P

Type of Activity: Application

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Additional Information

Participation in this self-study activity should be completed in approximately 2 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 12, 2022, through December 11, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.